106 related articles for article (PubMed ID: 3441164)
1. Correlative studies of the hypocholesterolemic effect of a highly activated charcoal.
Tishler PV; Winston SH; Bell SM
Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):799-806. PubMed ID: 3441164
[TBL] [Abstract][Full Text] [Related]
2. Sorbent therapy of the porphyrias. V. Adsorption of the porphyrin precursors delta-aminolevulinic acid and porphobilinogen by sorbents in vitro.
Winston SH; Tishler PV
Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):233-7. PubMed ID: 3724299
[TBL] [Abstract][Full Text] [Related]
3. Sorbent therapy of the porphyrias. IV. Adsorption of porphyrins by sorbents in vitro.
Tishler PV; Winston SH
Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):485-91. PubMed ID: 4079600
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
Denke MA; Grundy SM
Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022
[TBL] [Abstract][Full Text] [Related]
5. [The efficacy of cholestyramine as a hypocholesterolemic agent and its tolerance in a Mexican population].
Lerman Garber I; Cardoso Saldaña G; Zamora González J; Ahumada Ayala M; García Rubí E; Posadas Romero C
Arch Inst Cardiol Mex; 1991; 61(1):47-51. PubMed ID: 2048910
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
Day CE
Artery; 1990; 17(5):281-8. PubMed ID: 2396902
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
9. Fluvastatin in combination with other lipid-lowering agents.
Jokubaitis LA
Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270
[TBL] [Abstract][Full Text] [Related]
10. Fluvastatin in combination with other lipid-lowering agents.
Jokubaitis LA
Br J Clin Pract Suppl; 1996 Jan; 77A():28-32. PubMed ID: 8729588
[TBL] [Abstract][Full Text] [Related]
11. DEAE-Dextran in the treatment of primary hypercholesterolemia and/or hypercholesterolemia combined with hypertriglyceridemia. A multicentric randomized study on the efficacy of DEAE-Dextran compared with Cholestyramine.
Fedele F
Clin Ter; 2003; 154(4):231-6. PubMed ID: 14618939
[TBL] [Abstract][Full Text] [Related]
12. Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine.
Carrilho AJ; Medina WL; Nakandakare ER; Quintão EC
Clin Pharmacol Ther; 1997 Jul; 62(1):82-8. PubMed ID: 9246022
[TBL] [Abstract][Full Text] [Related]
13. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
Gylling H; Miettinen TA
Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of simvastatin and cholestyramine on plasma lipoproteins and CETP in humans.
McPherson R
Can J Clin Pharmacol; 1999; 6(2):85-90. PubMed ID: 10519734
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study.
Knopp RH; Tsunehara C; Retzlaff BM; Fish B; Nguyen H; Anderson S; Nguyen T
Metabolism; 2006 Dec; 55(12):1697-703. PubMed ID: 17142146
[TBL] [Abstract][Full Text] [Related]
16. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
[TBL] [Abstract][Full Text] [Related]
17. Hypocholesterolemic agents: a comparison of the relative effectiveness of cholestyramine and pectin in rats.
Baig MM; Burgin CW; Cerda JJ
Drug Nutr Interact; 1985; 3(2):109-13. PubMed ID: 3987520
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
Xydakis AM; Guyton JR; Chiou P; Stein JL; Jones PH; Ballantyne CM
Am J Cardiol; 2004 Sep; 94(6):795-7. PubMed ID: 15374793
[TBL] [Abstract][Full Text] [Related]
19. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
[TBL] [Abstract][Full Text] [Related]
20. The effect of cholestyramine on apolipoproteins in cholesterol-fed rabbits.
Lacombe C; Corraze G; Nibbelink M
Artery; 1986; 13(4):203-12. PubMed ID: 3707359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
